Biocapital II Lp Hbm serves as Executive at Allena Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Biocapital II Lp Hbm has executed 3 insider transactions totaling $1000.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 6, 2017 involved exercising options for 1,426,061 shares valued at $0.
Biocapital II Lp Hbm currently holds 1,426,061 shares of Allena Pharmaceuticals, Inc. (ALNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biocapital II Lp Hbm has been a net buyer of ALNA stock. They have purchased $1000.0K and sold $0 worth of shares.
Biocapital II Lp Hbm's most recent insider trade was on Nov 6, 2017, when they sold 1,426,061 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.00 |
| Discretionary |
| Nov 6, 2017 | ALNA | $0 | Conversion | 140,841 | $N/A | Discretionary |